13 results on '"Andersson, Anna-Maria"'
Search Results
2. Sex- and age-specific reference intervals of 16 steroid metabolites quantified simultaneously by LC-MS/MS in sera from 2458 healthy subjects aged 0 to 77 years
- Author
-
Frederiksen, Hanne, Johannsen, Trine Holm, Andersen, Stine Ehlern, Petersen, Jørgen Holm, Busch, Alexander Siegfried, Ljubicic, Marie Lindhardt, Fischer, Margit Bistrup, Upners, Emmie N., Hagen, Casper P., Main, Katharina M., Aksglaede, Lise, Jørgensen, Niels, Lund Kårhus, Line, Linneberg, Allan, Andersson, Anna-Maria, Flück, Christa E., and Juul, Anders
- Published
- 2024
- Full Text
- View/download PDF
3. Exposure to bisphenol A in European women from 2007 to 2014 using human biomonitoring data – The European Joint Programme HBM4EU
- Author
-
Tagne-Fotso, Romuald, Riou, Margaux, Saoudi, Abdessattar, Zeghnoun, Abdelkrim, Frederiksen, Hanne, Berman, Tamar, Montazeri, Parisa, Andersson, Anna-Maria, Rodriguez-Martin, Laura, Akesson, Agneta, Berglund, Marika, Biot, Pierre, Castaño, Argelia, Charles, Marie-Aline, Cocco, Emmanuelle, Den Hond, Elly, Dewolf, Marie-Christine, Esteban-Lopez, Marta, Gilles, Liese, Govarts, Eva, Guignard, Cedric, Gutleb, Arno C., Hartmann, Christina, Kold Jensen, Tina, Koppen, Gudrun, Kosjek, Tina, Lambrechts, Nathalie, McEachan, Rosemary, Sakhi, Amrit K., Snoj Tratnik, Janja, Uhl, Maria, Urquiza, Jose, Vafeiadi, Marina, Van Nieuwenhuyse, An, Vrijheid, Martine, Weber, Till, Zaros, Cécile, Tarroja-Aulina, Elena, Knudsen, Lisbeth E., Covaci, Adrian, Barouki, Robert, Kolossa-Gehring, Marike, Schoeters, Greet, Denys, Sebastien, Fillol, Clemence, and Rambaud, Loïc
- Published
- 2024
- Full Text
- View/download PDF
4. Prenatal and childhood exposure to bisphenols and bone mineral density in 7-year-old children from the Odense Child Cohort
- Author
-
Sigvaldsen, Annika, Frederiksen, Hanne, Højsager, Frederik Damsgaard, Andersson, Anna-Maria, Juul, Anders, Boye, Henriette, Andersen, Marianne Skovsager, and Jensen, Tina Kold
- Published
- 2024
- Full Text
- View/download PDF
5. Ovarian follicular fluid levels of phthalates and benzophenones in relation to fertility outcomes
- Author
-
Beck, Astrid L., Rehfeld, Anders, Mortensen, Li J., Lorenzen, Mette, Andersson, Anna-Maria, Juul, Anders, Bentin-Ley, Ursula, Krog, Hans, Frederiksen, Hanne, Petersen, Jørgen H., Holmboe, Stine A., and Jensen, Martin Blomberg
- Published
- 2024
- Full Text
- View/download PDF
6. Prenatal phthalate exposure and pubertal development in 16-year-old daughters: reproductive hormones and number of ovarian follicles.
- Author
-
Assens, Maria, Frederiksen, Hanne, Pedersen, Anette Tønnes, Petersen, Jørgen Holm, Andersson, Anna-Maria, Sundberg, Karin, Jensen, Lisa Neerup, Curtin, Paul, Skakkebæk, Niels E, Swan, Shanna H, and Main, Katharina M
- Subjects
SOMATOMEDIN C ,OVARIAN follicle ,GENITALIA ,REPRODUCTIVE health ,MALE reproductive health - Abstract
STUDY QUESTION Is there a possible association between prenatal phthalate exposure and late effects in teenage daughters with respect to reproductive hormone levels, uterine volume, and number of ovarian follicles? SUMMARY ANSWER Our study showed subtle associations between phthalate metabolite concentrations in maternal serum from pregnancy or cord blood and LH and insulin-like growth factor 1 (IGF-1) levels as well as uterine volume in their daughters 16 years later. WHAT IS KNOWN ALREADY Endocrine-disrupting environmental chemicals may adversely affect human reproductive health, and many societies have experienced a trend toward earlier puberty and an increasing prevalence of infertility in young couples. The scientific evidence of adverse effects of foetal exposure to a large range of chemicals, including phthalates, on male reproductive health is growing, but very few studies have explored effects on female reproduction. STUDY DESIGN, SIZE, DURATION This follow-up study included 317 teenage daughters who were part of the Copenhagen Mother–Child Cohort, a population-based longitudinal birth cohort of 1210 females born between 1997 and 2002. PARTICIPANTS/MATERIALS, SETTING, METHODS A total of 317 female participants (median age 16 years) were examined for weight, height, and menstrual pattern. A serum sample was analysed for concentrations of reproductive hormones, and trans-abdominal 3D ultrasonography was performed to obtain the number of ovarian follicles, ovarian and uterine size. Prenatal maternal serum samples were available for 115 females, and cord blood samples were available for 118 females. These were analysed for concentrations of 32 phthalate metabolites. Weighted quantile sum regression was used for modelling associations of combined prenatal phthalate exposure with the reproductive outcomes in post-menarcheal females. MAIN RESULTS AND THE ROLE OF CHANCE In bivariate correlation analyses, negative significant associations were found between several prenatal phthalate metabolite concentrations and serum hormone concentrations (testosterone, 17-OH-progesterone, and IGF-1) as well as number of ovarian follicles in puberty. Positive significant correlations were found between prenatal phthalate exposure and FSH and sex hormone-binding globulin concentrations. Combined analyses of phthalate exposure (weighted quantile sums) showed significant negative associations with IGF-1 concentration and uterine volume as well as a significant positive association with LH concentration. LIMITATIONS, REASONS FOR CAUTION Phthalate metabolites were measured in serum from single prenatal maternal blood samples and cord blood samples. Potential concomitant exposure to other endocrine-disrupting environmental chemicals before or after birth was not controlled for. The study population size was limited. WIDER IMPLICATIONS OF THE FINDINGS Our results support the need for further research into possible adverse effects of environmental chemicals during foetal development of the female reproductive system. STUDY FUNDING/COMPETING INTEREST(S) The work was supported by The Center on Endocrine Disruptors (CeHoS) under The Danish Environmental Protection Agency and The Ministry of Environment and Food (grant number: MST-621-00 065). No conflicts of interest are declared. TRIAL REGISTRATION NUMBER N/A. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Injection of luteinizing hormone or human chorionic gonadotropin increases calcium excretion and serum PTH in males
- Author
-
Mortensen, Li Juel, primary, Kooij, Ireen, additional, Lorenzen, Mette, additional, Jørgensen, Niklas Rye, additional, Røder, Andreas, additional, Jørgensen, Anne, additional, Andersson, Anna-Maria, additional, Juul, Anders, additional, and Jensen, Martin Blomberg, additional
- Published
- 2024
- Full Text
- View/download PDF
8. Enhanced identification of endocrine disruptors through integration of science-based regulatory practices and innovative methodologies: The MERLON Project
- Author
-
Svingen, Terje, primary, Andersson, Anna-Maria, additional, Angelova, Julianna, additional, Axelstad, Marta, additional, Bakker, Julie, additional, Baumann, Lisa, additional, Beronius, Anna, additional, Bouftas, Nora, additional, Chalmel, Frederic, additional, Christiansen, Sofie, additional, Cornil, Charlotte, additional, Damdimopoulou, Pauliina, additional, Deepika, Deepika, additional, Dollé, Martijn E. T., additional, Draskau, Monica Kam, additional, Fischer, Margit Bistrup, additional, Hagen, Casper P., additional, Hessel, Ellen, additional, Holmer, Marie Louise, additional, Hughes, Samantha, additional, Jensen, Genon, additional, Johansson, Hanna Katarina Lilith, additional, Juul, Anders, additional, Kumar, Vikas, additional, Kumar, Saurav, additional, Lardenois, Aurélie, additional, Main, Katharina M., additional, Mazaud-Guittot, Severine, additional, Moe, S. Jannicke, additional, Mola, Gylli, additional, Parent, Anne-Simone, additional, Pineda, Rafael, additional, Rolland, Antoine, additional, Rosenmai, Anna Kjerstine, additional, Song, You, additional, Suglia, Antonio, additional, Tena-Sempere, Manuel, additional, Wehrli, Lydia, additional, Zilliacus, Johanna, additional, and van Duursen, Majorie, additional
- Published
- 2024
- Full Text
- View/download PDF
9. The epidemiology of cryptorchidism and potential risk factors, including endocrine disrupting chemicals
- Author
-
Holmboe, Stine A., primary, Beck, Astrid L., additional, Andersson, Anna-Maria, additional, Main, Katharina M., additional, Jørgensen, Niels, additional, Skakkebæk, Niels E., additional, and Priskorn, Lærke, additional
- Published
- 2024
- Full Text
- View/download PDF
10. The epidemiology of cryptorchidism and potential risk factors, including endocrine disrupting chemicals
- Author
-
Holmboe, Stine A., Beck, Astrid L., Andersson, Anna Maria, Main, Katharina M., Jørgensen, Niels, Skakkebæk, Niels E., Priskorn, Lærke, Holmboe, Stine A., Beck, Astrid L., Andersson, Anna Maria, Main, Katharina M., Jørgensen, Niels, Skakkebæk, Niels E., and Priskorn, Lærke
- Abstract
Congenital cryptorchidism, also known as undescended testis, is the condition where one or both testes are not in place in the scrotum at birth and is one of the most common birth defects in boys. Temporal trends and geographic variation in the prevalence of cryptorchidism from 1% to 9% have been reported in prospective cohort studies. The testes develop in the abdominal cavity and descend to the scrotum in two phases, which should be completed by gestational week 35. Thus, the risk of cryptorchidism is higher in preterm boys. In many cases a spontaneous descent occurs during the first months of life during the surge of gonadotropins and testosterone. If not, the testis is usually brought down to the scrotum, typically by surgery, to increase future fertility chances and facilitate cancer surveillance. The increasing frequency of impaired semen quality and testicular cancer, with which cryptorchidism is associated, represents a concern for male reproductive health in general and a need to understand its risk factors. The risk of cryptorchidism is closely related to gestational factors (preterm birth, low birth weight and intrauterine growth restriction), and especially maternal smoking seems to be a risk factor. Evidence is accumulating that the increasing prevalence of cryptorchidism is also related to prenatal exposure to environmental chemicals, including endocrine disrupting compounds. This association has been corroborated in rodents and supported by ecological studies. Conducting human studies to assess the effect of endocrine disrupting chemicals and their interactions is, however, challenged by the widespread concomitant exposure of all humans to a wide range of chemicals, the combined effect of which and their interactions are highly complex., Congenital cryptorchidism, also known as undescended testis, is the condition where one or both testes are not in place in the scrotum at birth and is one of the most common birth defects in boys. Temporal trends and geographic variation in the prevalence of cryptorchidism from 1% to 9% have been reported in prospective cohort studies. The testes develop in the abdominal cavity and descend to the scrotum in two phases, which should be completed by gestational week 35. Thus, the risk of cryptorchidism is higher in preterm boys. In many cases a spontaneous descent occurs during the first months of life during the surge of gonadotropins and testosterone. If not, the testis is usually brought down to the scrotum, typically by surgery, to increase future fertility chances and facilitate cancer surveillance. The increasing frequency of impaired semen quality and testicular cancer, with which cryptorchidism is associated, represents a concern for male reproductive health in general and a need to understand its risk factors. The risk of cryptorchidism is closely related to gestational factors (preterm birth, low birth weight and intrauterine growth restriction), and especially maternal smoking seems to be a risk factor. Evidence is accumulating that the increasing prevalence of cryptorchidism is also related to prenatal exposure to environmental chemicals, including endocrine disrupting compounds. This association has been corroborated in rodents and supported by ecological studies. Conducting human studies to assess the effect of endocrine disrupting chemicals and their interactions is, however, challenged by the widespread concomitant exposure of all humans to a wide range of chemicals, the combined effect of which and their interactions are highly complex.
- Published
- 2024
11. Antibiotic Use in Dental Care of Dogs, Cats, and Rabbits in Sweden.
- Author
-
Ljungquist, Ditte, Andersson, Magnus, Areskog, Marlene, and Andersson, Anna-Maria
- Abstract
Antimicrobial resistance is one of the largest threats to global health. In society as well as in healthcare facilities, antimicrobial resistance is rapidly increasing with the main reason being overuse and misuse of antibiotics combined with inadequate infection prevention. For humans, dental care accounts for about 10% of all antibiotic prescriptions, making it an important target for antibiotic stewardship interventions. Corresponding figures for veterinary care are currently lacking but dental disease is frequently diagnosed in small animals. An important first step in the work towards prudent use of antibiotics is to understand antibiotic prescription habits and through that estimate the adherence to veterinary antibiotic guidelines as well as the need for education, training, and improved policies. The aim of this article is to present the results of a multicentre point prevalence survey sent to Swedish IVC Evidensia practices during autumn 2021 to recognize the use of antibiotics associated with dental treatments in dogs, cats, and rabbits. During the study period, 4.4% of the dental patients in Swedish IVC Evidensia small animal veterinary practices received antibiotics. The most used antibiotics prescribed were ampicillin, amoxicillin, and clindamycin indicating an overall high level of compliance to veterinary dental guidelines. This article demonstrates that Swedish veterinarians use antibiotics prudently in small animal dentistry and the results may be used as a future global benchmark. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Serum Concentrations of Inhibin B in Healthy Females and Males Throughout Life.
- Author
-
Borelli-Kjær A, Aksglaede L, Jensen RB, Hagen CP, Ljubicic ML, Busch AS, Upners EN, Fischer MB, Jensen TK, Linneberg A, Kårhus LL, Andersson AM, Petersen JH, Juul A, and Johannsen TH
- Abstract
Objective: To describe the natural history of inhibin B throughout life according to sex, age, and pubertal development., Methods: Based on serum samples from 2707 healthy controls aged 0 to 80 years, sex- and age-specific reference ranges of inhibin B concentrations were constructed. Concentrations were evaluated according to pubertal development and use of oral contraceptives (OCs). Also, measurements from 42 patients with Klinefelter syndrome were included., Results: In both sexes, inhibin B concentrations were high during minipuberty, decreased in childhood, and increased significantly from Tanner stages B1 to B3 (peak: B4) in females and from G1 to G3 (peak: G3) in males. Despite variations in menstruating females, inhibin B concentrations remained relatively constant after puberty, until becoming unmeasurable at menopause. Despite a modest decrease, the inhibin B concentration in males remained relatively high from puberty onwards. At any age, males had highest concentrations. Inhibin B standard deviation (SD) scores were lower in OC-users (median SD score = -0.88) than in non-users (SD score = 0.35), p < 0.001. In patients with Klinefelter syndrome, inhibin B concentrations spanned the reference range until around 15 years of age, where they decreased to subnormal or unmeasurable levels., Conclusion: Valuable sex- and age-specific reference data for inhibin B concentrations were provided. In OC-users, decreased concentrations of inhibin B underlined the ovaries as the only place of inhibin B production. In patients with Klinefelter syndrome, the decline in inhibin B concentrations at puberty underlined the shift in regulation of inhibin B production at pubertal onset., (© The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. See the journal About page for additional terms.)
- Published
- 2024
- Full Text
- View/download PDF
13. Longitudinal evaluation of fetal and infant AGD in healthy children: association with penile size, testosterone and DHT.
- Author
-
Fischer MB, Mola G, Priskorn L, Scheel L, Hegaard HK, Sundberg K, Frederiksen H, Andersson AM, Juul A, and Hagen CP
- Abstract
Context: The anogenital distance (AGD) is considered a postnatal readout of early fetal androgen action. Little is known of prenatal AGD and how it correlates with AGD postnatally., Objectives: We present longitudinal measurements of fetal- and infant AGD. We evaluate the impact of testosterone and dihydrotestosterone at minipuberty on AGD and penile size., Design: Secondary analyses of an observational, prospective pregnancy and birth cohort, COPANA (2020-2022)., Setting: Copenhagen University Hospital - Rigshospitalet., Participants: 685 healthy, singleton pregnant women enrolled, 657 women attended 3rd trimester ultrasound, 589 infants completed follow-up., Main Outcome Measures: 3rd trimester ultrasound (GW29-34): Fetal AGD. Minipuberty clinical examination (app. 3.5 months postpartum): infant AGD, penile width and stretched length (SPL), circulating testosterone and dihydrotestosterone (LC-MS/MS)., Results: AGD was available in 650/657 fetuses (310 boys) and 588/589 infants (287 boys). Boys had longer fetal and infant AGD compared to girls; fetal AGDas: mean (SD) 21.4 mm (±3.5), fetal AGDaf: 12.8 mm (±2.3), p < 0.001, infant AGDas: 32.0 mm (±5.6) and infant AGDaf: 15.8 (±3.3), p < 0.001. Fetal AGD correlated with infant AGD in boys and girls (Spearman's r = 0.275, p < 0.001 and r = 0.189, p = 0.001 respectively), but not with circulating testosterone or dihydrotestosterone at minipuberty. Penile size correlated positively with circulating androgen levels at minipuberty, i.e.: SPL vs testosterone: r = 0.235, p < 0.001., Conclusions: AGD is sexual dimorphic already in the 3rd trimester. Fetal and infant AGD correlates. AGD is associated with body size but not circulating androgen levels at minipuberty. These findings suggest that fetal and infant AGD, reflect androgen action during early fetal development., (© The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.